BIXT
Price
$0.09
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
7.65M
BSEM
Price
$11.64
Change
-$0.22 (-1.85%)
Updated
Jul 25 closing price
Capitalization
194.37M
30 days until earnings call
Interact to see
Advertisement

BIXT vs BSEM

Header iconBIXT vs BSEM Comparison
Open Charts BIXT vs BSEMBanner chart's image
Bioxytran
Price$0.09
Change-$0.00 (-0.00%)
Volume$37.3K
Capitalization7.65M
BioStem Technologies
Price$11.64
Change-$0.22 (-1.85%)
Volume$19.57K
Capitalization194.37M
BIXT vs BSEM Comparison Chart in %
Loading...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIXT vs. BSEM commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIXT is a Hold and BSEM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (BIXT: $0.09 vs. BSEM: $11.64)
Brand notoriety: BIXT and BSEM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIXT: 29% vs. BSEM: 39%
Market capitalization -- BIXT: $7.65M vs. BSEM: $194.37M
BIXT [@Biotechnology] is valued at $7.65M. BSEM’s [@Biotechnology] market capitalization is $194.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIXT’s FA Score shows that 1 FA rating(s) are green whileBSEM’s FA Score has 0 green FA rating(s).

  • BIXT’s FA Score: 1 green, 4 red.
  • BSEM’s FA Score: 0 green, 5 red.
According to our system of comparison, BIXT is a better buy in the long-term than BSEM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIXT’s TA Score shows that 4 TA indicator(s) are bullish while BSEM’s TA Score has 5 bullish TA indicator(s).

  • BIXT’s TA Score: 4 bullish, 3 bearish.
  • BSEM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BIXT is a better buy in the short-term than BSEM.

Price Growth

BIXT (@Biotechnology) experienced а -9.30% price change this week, while BSEM (@Biotechnology) price change was +3.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

BSEM is expected to report earnings on Aug 26, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSEM($194M) has a higher market cap than BIXT($7.65M). BIXT has higher P/E ratio than BSEM: BIXT (40.65) vs BSEM (7.92). BIXT YTD gains are higher at: -4.338 vs. BSEM (-15.867). BSEM has more cash in the bank: 110K vs. BIXT (4.35K). BIXT has less debt than BSEM: BIXT (1.26M) vs BSEM (6.02M).
BIXTBSEMBIXT / BSEM
Capitalization7.65M194M4%
EBITDA-2.38MN/A-
Gain YTD-4.338-15.86727%
P/E Ratio40.657.92513%
Revenue0N/A-
Total Cash4.35K110K4%
Total Debt1.26M6.02M21%
FUNDAMENTALS RATINGS
BIXT vs BSEM: Fundamental Ratings
BIXT
BSEM
OUTLOOK RATING
1..100
504
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
54
Fair valued
PROFIT vs RISK RATING
1..100
10059
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6564
P/E GROWTH RATING
1..100
10072
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIXT's Valuation (1) in the null industry is somewhat better than the same rating for BSEM (54). This means that BIXT’s stock grew somewhat faster than BSEM’s over the last 12 months.

BSEM's Profit vs Risk Rating (59) in the null industry is somewhat better than the same rating for BIXT (100). This means that BSEM’s stock grew somewhat faster than BIXT’s over the last 12 months.

BSEM's SMR Rating (100) in the null industry is in the same range as BIXT (100). This means that BSEM’s stock grew similarly to BIXT’s over the last 12 months.

BSEM's Price Growth Rating (64) in the null industry is in the same range as BIXT (65). This means that BSEM’s stock grew similarly to BIXT’s over the last 12 months.

BSEM's P/E Growth Rating (72) in the null industry is in the same range as BIXT (100). This means that BSEM’s stock grew similarly to BIXT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIXTBSEM
RSI
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
71%
Aroon
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYDCX107.291.43
+1.35%
Rydex Mid-Cap 1.5x Strategy C
LMCJX9.030.04
+0.44%
Miller Income A
PRJCX40.960.17
+0.42%
PGIM Jennison Global Opportunities C
GLPCX30.83-0.11
-0.36%
Goldman Sachs MLP Energy Infras C
HFCIX55.76-1.41
-2.47%
Hennessy Focus Institutional

BIXT and

Correlation & Price change

A.I.dvisor tells us that BIXT and CING have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIXT and CING's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIXT
1D Price
Change %
BIXT100%
-6.37%
CING - BIXT
26%
Poorly correlated
+2.42%
CYTK - BIXT
22%
Poorly correlated
-0.35%
APLM - BIXT
21%
Poorly correlated
+1.30%
ANEB - BIXT
20%
Poorly correlated
-1.54%
TTNP - BIXT
20%
Poorly correlated
-20.72%
More

BSEM and

Correlation & Price change

A.I.dvisor tells us that BSEM and VICP have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSEM and VICP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSEM
1D Price
Change %
BSEM100%
-1.82%
VICP - BSEM
23%
Poorly correlated
N/A
BMNDF - BSEM
11%
Poorly correlated
N/A
BVNRY - BSEM
9%
Poorly correlated
+0.33%
BIXT - BSEM
6%
Poorly correlated
-6.37%
CMVLF - BSEM
5%
Poorly correlated
N/A
More